Thomas Putz

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag. Active years: 2009-2011.

USPTO Granted Patents = 2

% Patents Active = 50.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

2 out of 3

Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag

patents

Years Active: 2009-2011

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8034338 - Immunogenic recombinant antibody (2011-10-11),

2. 7527789 - Use of a preparation based on an antibody directed against a tumor-associated glycosylation (2009-05-05),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]

1 patent pending (EPO):

Please report any incorrect information to [email protected]